Search
Displaying 241–250 of 1059 results for “fc 26 ps4 coins Visit Buyfc26coins.com for latest FC 26 coins news..NH7v”
-
AGTC Planning Phase 2/3 Clinical Trial for XLRP Gene Therapy
Research NewsThe company is also expanding its Phase ½ trial for the emerging treatment
-
Acucela Enrolling Patients in Phase 3 Trial for Stargardt Disease Treatment
Research NewsThe Seattle biotech Acucela is now enrolling participants in its Phase 3 clinical trial for emixustat hydrochloride, an emerging oral drug for slowing vision loss in people with Stargardt disease, an inherited form of a macular degeneration.
-
Building a Wiring Diagram for the Retina to Help Researchers Save and Restore Vision
Research NewsUnderstanding the pathways of the retinal neural network — and how they are rewired with aging and disease — is helpful in trying to save and restore vision.
-
DHA and EPA for Stargardt Disease — an Evolving Story
Research NewsThese healthy fats have exciting potential for treating a wide range of retinal degenerations and other health conditions.
-
A Retinal Research Nonprofit Paves the Way for Commercializing Gene Therapies
In the PressAN EMERGING, vision-restoring gene therapy for a devastating retinal disease is poised for Food and Drug Administration (FDA) approval. If it gets the regulatory nod, it will be the first gene therapy to receive FDA approval for the eye or an inherited condition.
-
Summary of the Ninth Annual Retinal Cell & Gene Therapy Innovation Summit 2024
Foundation NewsIn its ninth year, the Innovation Summit featured more than 30 presentations from retina experts from around the world with nearly 420 people in attendance.
-
AAVantgarde Completes Enrollment in Retinal Gene Therapy Trial for Usher Syndrome Type 1B
Research NewsMilestone brings hope to patients with rare inherited retinal disease
-
Research News
First patient treated in Part B of ASTRA trial evaluating SB-007.
-
Opus Genetics Receives FDA Clearance to Launch Clinical Trial for Best1 Gene Therapy
Research NewsThe Foundation funded earlier, proof-of-concept studies for the Best1 gene therapy and later launched Opus to develop several IRD gene therapies.
-
ARVO 2024 Highlight: InGel’s Cell Therapy Shows Promise for Preserving Vision
Research NewsThe emerging treatment is designed to work for people with RP and other conditions regardless of the gene mutation causing disease
